INACTIVATION OF OXYTOCIN AND VASOPRESSIN BY TISSUE ENZYMES - A BASIS FOR DESIGN OF ANALOGUES

被引：0
|
作者：
RYCHLIK, I
机构：
来源：
BIOCHEMICAL PHARMACOLOGY | 1963年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：141 / &
相关论文
共 50 条
  • [31] Analogues of arginine vasopressin modified at position 2 with proline derivatives: selective antagonists of oxytocin in vitro
    Sobolewski, Dariusz
    Prahl, Adam
    Slaninova, Jirina
    Lammek, Bernard
    PEPTIDES FOR YOUTH, 2009, 611 : 503 - 504
  • [32] TISSUE BASIS FOR THE USE OF ENZYMES IN EXPERIMENTAL TOXICOLOGY
    BRAUN, JP
    BENARD, P
    BURGAT, V
    RICO, AG
    ANNALES DE BIOLOGIE CLINIQUE, 1982, 40 (04) : 376 - 377
  • [33] EXPLORING BIOACTIVE PEPTIDES AS PHARMACOLOGICAL TOOLS FOR OXYTOCIN AND VASOPRESSIN LIGAND DESIGN
    Gruber, C.
    Koehbach, J.
    Freissmuth, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 120 - 120
  • [34] INVITRO RELEASE OF VASOPRESSIN AND OXYTOCIN FROM RAT MEDIAN-EMINENCE TISSUE
    VERBALIS, JG
    BALDWIN, EF
    RONNEKLEIV, OK
    ROBINSON, AG
    NEUROENDOCRINOLOGY, 1986, 42 (06) : 481 - 488
  • [35] DESIGN AND USES OF SELECTIVE AGONISTIC AND ANTAGONISTIC ANALOGS OF THE NEUROPEPTIDES OXYTOCIN AND VASOPRESSIN
    MANNING, M
    SAWYER, WH
    TRENDS IN NEUROSCIENCES, 1984, 7 (01) : 6 - 9
  • [36] Histidine analogues of oxytocin and vasopressin as efficient ligands for Zn2+ ions - Potentiometric and NMR studies
    Brasun, Justyna
    Cebrat, Marek
    Jaremko, Mariusz
    Jaremko, Lukasz
    Gladysz, Olimpa
    Zhukov, Igor
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2009, 103 (07) : 1033 - 1038
  • [37] Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule
    Kowalczyk, W
    Prahl, A
    Derdowska, I
    Sobolewski, D
    Olejnik, J
    Zabrocki, J
    Borovicková, L
    Slaninová, J
    Larnmek, B
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (06) : 2016 - 2021
  • [38] Analogues of arginine vasopressin modified in position 2 or 3 with naphthylalanine: Selective antagonists of oxytocin in-vitro
    Sobocinska, M
    Lempicka, E
    Konieczna, E
    Derdowska, I
    Lammek, B
    Melhem, S
    Kozik, W
    Janecka, J
    Janecki, M
    Trzeciak, HI
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (09) : 1105 - 1112
  • [39] ACTIVATION AND INACTIVATION OF OXYTOCIN AND VASOPRESSIN RELEASE FROM ISOLATED NERVE-ENDINGS (NEUROSECRETOSOMES) OF THE RAT NEUROHYPOPHYSIS
    PAYZA, K
    RUSSELL, JT
    JOURNAL OF NEUROCHEMISTRY, 1991, 57 (02) : 499 - 508
  • [40] Design of novel bicyclic analogues derived from a potent oxytocin antagonist
    Flouret, George
    Chaloin, Olivier
    Borovickova, Lenka
    Slaninova, Jirina
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 (06) : 412 - 419
12345